Ledger.Open graph →

SEC Form D · filed October 21, 2020

Chinook Therapeutics U.S., Inc

Offering

$115.0M

Sold

$115.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Jeremy Caldwell · SAN DIEGO, CADirector Jerel Davis · Cleveland, OHDirector Preston Klassen · Seattle, WADirector Eric Dobmeier · Seattle, WAExec · Director David Ron · Berkeley, CADirector Stephen Plume · Berkeley, CADirector Gregorio Schneider · Berkeley, CAExec · Director Andrew King · West Perth, Channel IslandsExec Tom Frolich · Seattle, WAExec Paul Eisenberg · New York, NYDirector Srinivas Akkaraju · Bothell, WADirector Alan Glicklich · Seattle, WAExec Lyle Berkowitz · Chicago, ILDirector Mark Bakken · Madison, WIDirector Derek Kim · CHEYENNE, WYExec · Director Andrew King · Gig Harbor, WAExec Tom Frolich · Seattle, WAExec Preston Klassen · Seattle, WADirector Paul Eisenberg · New York, NYDirector Srinivas Akkaraju · SOUTH SAN FRANCISCO, CADirector Alan Glicklich · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗